These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6252408

  • 1. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN, Tarasov NF, Koval'chuk ND, Levin VI, Boldyrev PP.
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP, Mechev DS.
    Eksp Onkol; 1985 Sep; 7(1):66-7. PubMed ID: 2983974
    [Abstract] [Full Text] [Related]

  • 3. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R, Neumann R, Goldsmith SJ.
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [Abstract] [Full Text] [Related]

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [Abstract] [Full Text] [Related]

  • 6. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Coupal JJ.
    Calcif Tissue Int; 1981 Oct; 33(5):555. PubMed ID: 6797708
    [No Abstract] [Full Text] [Related]

  • 7. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A, Martini G.
    Boll Soc Ital Biol Sper; 1983 Nov 30; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract] [Full Text] [Related]

  • 8. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J, van Steijn AM, Gelsema WJ, de Ligny CL.
    Int J Nucl Med Biol; 1986 Nov 30; 12(6):411-7. PubMed ID: 3011692
    [Abstract] [Full Text] [Related]

  • 9. [Accumulation of sodium 2,3-dicarboxypropan-1,1-diphosphonate in bone of rabbits (author's transl)].
    Nagai K, Otsuka N, Terashima H, Yanagimoto S, Nagase N, Muranaka A, Ito Y.
    Radioisotopes; 1982 Apr 30; 31(4):197-8. PubMed ID: 6213983
    [No Abstract] [Full Text] [Related]

  • 10. [Retention of 99mTc-diphosphonate in the bones and soft tissues of rats: distribution, time factors, the effect of age].
    Kapitola J, Kobos L, Jahoda I, Vilimovská D.
    Sb Lek; 1987 Apr 30; 89(2-3):60-6. PubMed ID: 3589471
    [No Abstract] [Full Text] [Related]

  • 11. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C, Hohloch H, Schiller A, Pohle W, Hoffmann G.
    Nuklearmedizin; 1979 May 30; 18(2):98-104. PubMed ID: 38438
    [Abstract] [Full Text] [Related]

  • 12. Optimizing the performance and interpretation of bone scans.
    Muroff LR.
    Clin Nucl Med; 1981 Oct 30; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract] [Full Text] [Related]

  • 13. Drug-induced modulation of Tc-99m pyrophosphate tissue distribution: what is involved?
    Wahner HW, Dewanjee MK.
    J Nucl Med; 1981 Jun 30; 22(6):555-9. PubMed ID: 6262466
    [No Abstract] [Full Text] [Related]

  • 14. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Caniggia A, Vattimo A.
    Calcif Tissue Int; 1980 Jun 30; 30(1):5-13. PubMed ID: 6767533
    [No Abstract] [Full Text] [Related]

  • 15. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C.
    Ann Radiol (Paris); 1983 Jun 30; 26(6):498-504. PubMed ID: 6316830
    [No Abstract] [Full Text] [Related]

  • 16. Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives.
    Bisaz S, Jung A, Fleisch H.
    Clin Sci Mol Med; 1978 Mar 30; 54(3):265-72. PubMed ID: 204442
    [Abstract] [Full Text] [Related]

  • 17. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A, Cantalupi D, Righi G, Martini G, Nuti R, Turchetti V.
    J Nucl Med Allied Sci; 1981 Mar 30; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract] [Full Text] [Related]

  • 18. [Sodium pyrophosphate labeled by technetium 99m in the study of bone metastases. Role and limitations of the examination].
    Ducassou D, Pigneux J, Leccia F, Brendel A.
    J Radiol Electrol Med Nucl; 1975 Mar 30; 56 suppl 2():562-3. PubMed ID: 182998
    [No Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD, Ferguson DL, Tofe AJ, Bevan JA, Michaels SE.
    J Nucl Med; 1980 Dec 30; 21(12):1185-9. PubMed ID: 6449567
    [Abstract] [Full Text] [Related]

  • 20. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C, Hohloch M, Hoffmann G.
    Nuklearmedizin; 1979 May 30; 18(2):105-9. PubMed ID: 38437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.